loadpatents
Patent applications and USPTO patent grants for Goulet; Mark T..The latest application filed is for "diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use".
Patent | Date |
---|---|
Radiolabeled cannabinoid-1 receptor modulators Grant 7,754,188 - Burns , et al. July 13, 2 | 2010-07-13 |
Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds And Methods Of Use App 20100152185 - Chu; Lin ;   et al. | 2010-06-17 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists Grant 7,700,778 - Goulet , et al. April 20, 2 | 2010-04-20 |
Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use Grant 7,629,467 - Chu , et al. December 8, 2 | 2009-12-08 |
Anti-hypercholesterolemic compounds Grant 7,622,449 - Goulet , et al. November 24, 2 | 2009-11-24 |
Inhibitors of Fatty Acid Synthase (Fas) App 20090048276 - Goulet; Mark T. ;   et al. | 2009-02-19 |
Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists Grant 7,423,067 - Hagmann , et al. September 9, 2 | 2008-09-09 |
Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use App 20060211677 - Chu; Lin ;   et al. | 2006-09-21 |
Substituted furo[2,3-b]pyridine derivatives Grant 7,091,216 - Toupence , et al. August 15, 2 | 2006-08-15 |
Substituted amides App 20060115425 - Burns; H. Donald ;   et al. | 2006-06-01 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists Grant 7,015,235 - Goulet , et al. March 21, 2 | 2006-03-21 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists Grant 7,012,084 - Goulet , et al. March 14, 2 | 2006-03-14 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists App 20060035935 - Goulet; Mark T. ;   et al. | 2006-02-16 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists App 20060025442 - Goulet; Mark T. ;   et al. | 2006-02-02 |
Substituted furo[2,3-b]pyridine derivatives App 20050272763 - Toupence, Richard B. ;   et al. | 2005-12-08 |
Anti-hypercholesterolemic compounds App 20050267049 - Goulet, Mark T. ;   et al. | 2005-12-01 |
Spirocyclic amides as cannabinoid receptor modulators App 20050239828 - Hagmann, William K. ;   et al. | 2005-10-27 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists App 20040266821 - Ujjainwalla, Feroze ;   et al. | 2004-12-30 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists Grant 6,818,658 - Ujjainwalla , et al. November 16, 2 | 2004-11-16 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists App 20040097546 - Goulet, Mark T. ;   et al. | 2004-05-20 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists App 20040092501 - Goulet, Mark T. ;   et al. | 2004-05-13 |
Acylated piperidine derivatives as melanocortin-4 receptor agonists App 20030225060 - Ujjainwalla, Feroze ;   et al. | 2003-12-04 |
Antagonists of gonadotropin releasing hormone Grant 6,077,847 - Walsh , et al. June 20, 2 | 2000-06-20 |
Antagonists of gonadotropin releasing hormone Grant 6,025,366 - Walsh , et al. February 15, 2 | 2000-02-15 |
Antagonists of gonadotropin releasing hormone Grant 5,998,432 - Walsh , et al. December 7, 1 | 1999-12-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.